Medpace Holdings, Inc. (MEDP)
466.94
+9.04
(+1.97%)
USD |
NASDAQ |
Jun 09, 16:00
466.94
0.00 (0.00%)
After-Hours: 19:14
Medpace Holdings EPS Diluted (Quarterly) : 4.277 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inotiv, Inc. | -0.9369 |
| Avantor, Inc. | 0.064 |
| Adaptive Biotechnologies Corp. | -0.1288 |
| 10X Genomics, Inc. | -0.105 |
| Champions Oncology, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 123.87M |
| Revenue (Quarterly) | 706.60M |
| Total Expenses (Quarterly) | 582.73M |
| Enterprise Value | 12.54B |
| Gross Profit Margin (Quarterly) | 26.81% |
| Profit Margin (Quarterly) | 17.53% |
| Earnings Yield | 3.40% |
| Operating Earnings Yield | 4.16% |
| Normalized Earnings Yield | 3.404 |